基因治疗与年龄相关的黄斑变性:潜力,可行性和陷
Sean T Berkowitz1, Avni P Finn
1Vanderbilt University Medical Center, Department of Ophthalmology, Nashville, Tennessee, USA.
Current opinion in ophthalmology
|March 5, 2024
概括
新的基因疗法为与年龄相关的黄斑变性 (AMD) 提供了希望,包括非神经血管性AMD (nnAMD). 研究人员正在完善传递方法和病毒载体,以提高安全性和有效性,解决像免疫性等问题的问题.
科学领域:
- 眼科医生 眼科 眼科
- 基因治疗 基因治疗
- 视网膜疾病 视网膜疾病
背景情况:
- 与年龄相关的黄斑变性 (AMD) 的治疗环境正在随着新的生物类似药物和FDA批准的非神经血管性AMD (nnAMD) 疗法而发展.
- 针对VEGF和补充通路的基因疗法方法正在新出现,用于新血管AMD (nAMD) 和nnAMD.
- 过去的基因疗法挫折,包括眼内炎症,强调需要在AMD治疗中仔细评估安全性.
结论:
- 新兴的基因疗法有可能为nAMD和nnAMD开发更持久的治疗方法.
- 需要完善输送途径,载体和剂量,并仔细分析患者特定的风险和益处.
- 载体技术和输送技术的持续进步对于提高AMD基因疗法的安全性和有效性至关重要.
更多相关视频
07:04Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
2.0K
06:16Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies
Published on: July 28, 2023
2.5K
相关概念视频
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
